Home
>
National Drug Code (NDC)
>
Ziac
Ziac - 51285-047-02 - (bisoprolol fumarate and hydrochlorothiazide)
Drug Information of Ziac
| Product NDC: | 51285-047 |
| Proprietary Name: | Ziac |
| Non Proprietary Name: | bisoprolol fumarate and hydrochlorothiazide |
| Active Ingredient(s): | 2.5; 6.25 mg/1; mg/1 & nbsp; bisoprolol fumarate and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ziac
| Product NDC: | 51285-047 |
| Labeler Name: | Teva Women's Health, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020186 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19930326 |
Package Information of Ziac
| Package NDC: | 51285-047-02 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (51285-047-02) |
NDC Information of Ziac
| NDC Code | 51285-047-02 |
| Proprietary Name | Ziac |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (51285-047-02) |
| Product NDC | 51285-047 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bisoprolol fumarate and hydrochlorothiazide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19930326 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Women's Health, Inc. |
| Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
| Strength Number | 2.5; 6.25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
